↓ Skip to main content

A human induced pluripotent stem cell-based modular platform to challenge sensorineural hearing loss

Overview of attention for article published in Stem Cells, February 2021

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter
7 X users
patent
1 patent
facebook
3 Facebook pages

Readers on

mendeley
62 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
A human induced pluripotent stem cell-based modular platform to challenge sensorineural hearing loss
Published in
Stem Cells, February 2021
DOI 10.1002/stem.3346
Pubmed ID
Authors
Abstract

The sense of hearing depends on a specialized sensory organ in the inner ear, called the cochlea, which contains the auditory hair cells (HCs). Noise trauma, infections, genetic factors, side effects of ototoxic drugs (ie, some antibiotics and chemotherapeutics) or simply aging lead to the loss of HCs and their associated primary neurons. This results in irreversible sensorineural hearing loss (SNHL) as in mammals, including humans; the inner ear lacks the capacity to regenerate HCs and spiral ganglion neurons. SNHL is a major global health problem affecting millions of people worldwide and provides a growing concern in the aging population. To date, treatment options are limited to hearing aids and cochlear implants. A major bottleneck for development of new therapies for SNHL is associated to the lack of human otic cell bioassays. Human induced pluripotent stem cells (hiPSCs) can be induced in 2D and 3D otic cells in vitro models that can generate inner ear progenitors and sensory HCs and could be a promising preclinical platform from which to work toward restoring SNHL. We review the potential applications of hiPSCs in the various biological approaches, including disease modeling, bioengineering, drug testing and autologous stem cell based-cell therapy, that offer opportunities to understand the pathogenic mechanisms of SNHL and identify novel therapeutic strategies. © AlphaMed Press 2021 SIGNIFICANCE STATEMENT: Sensorineural hearing loss is the world's most common sensory deficit and affects nearly 470 million people. Discovery of hiPSCs has allowed the derivation of patient-specific stem cells; they can self-renew and have the capacity to differentiate into otic neurosensory cell derivatives, facilitating the study of disease mechanisms, bioengineering, and stem cell-based cell replacement therapies either as individual cell types or as organoid 3D cultures. We highlight major achievements of, as well as challenges associated with, hiPSC-based otic cell modeling as a human preclinical platform to understand pathogenesis and identify novel therapies.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 62 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 6 10%
Student > Bachelor 5 8%
Researcher 5 8%
Student > Master 4 6%
Other 2 3%
Other 2 3%
Unknown 38 61%
Readers by discipline
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 11%
Medicine and Dentistry 5 8%
Neuroscience 3 5%
Engineering 3 5%
Agricultural and Biological Sciences 2 3%
Other 2 3%
Unknown 40 65%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 August 2024.
All research outputs
#5,682,950
of 33,992,632 outputs
Outputs from Stem Cells
#1,404
of 4,462 outputs
Outputs of similar age
#112,598
of 582,062 outputs
Outputs of similar age from Stem Cells
#16
of 52 outputs
Altmetric has tracked 33,992,632 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,462 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 582,062 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.